Network pharmacology and molecular docking results revealed that several blood-brain barrier (BBB)-permeable active components of <i>Lonicera caerulea</i>, including Naringenin and Palmatine, may be associated with targets involved in the lipid and atherosclerosis pathway, such as HSP90AA1, SRC and TNF. The gene discussed is SRC; the disease is atherosclerosis.